Cargando…

Peptide Shuttles for Blood–Brain Barrier Drug Delivery

The blood–brain barrier (BBB) limits the delivery of therapeutics to the brain but also represents the main gate for nutrient entrance. Targeting the natural transport mechanisms of the BBB offers an attractive route for brain drug delivery. Peptide shuttles are able to use these mechanisms to incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Navarro, Macarena, Giralt, Ernest
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505527/ https://www.ncbi.nlm.nih.gov/pubmed/36145622 http://dx.doi.org/10.3390/pharmaceutics14091874

Ejemplares similares

Branched BBB-shuttle peptides: chemoselective modification of proteins to enhance blood–brain barrier transport
por: Díaz-Perlas, Cristina, et al.
Publicado: (2018)

Peptide Mediated Brain Delivery of Nano- and Submicroparticles: A Synergistic  Approach
por: McCully, Mark, et al.
Publicado: (2018)

Conjugation of a Blood Brain Barrier Peptide Shuttle to an Fc Domain for Brain Delivery of Therapeutic Biomolecules
por: Cavaco, Marco, et al.
Publicado: (2021)

Novel Blood–Brain Barrier Shuttle Peptides Discovered through the Phage Display Method
por: Majerova, Petra, et al.
Publicado: (2020)

Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies
por: Park, Tae-Eun, et al.
Publicado: (2019)

Modulation of the Blood–Brain Barrier for Drug Delivery to Brain
por: Han, Liang
Publicado: (2021)

Target-templated de novo design of macrocyclic d-/l-peptides: discovery of drug-like inhibitors of PD-1
por: Guardiola, Salvador, et al.
Publicado: (2021)

Nanoscale drug delivery systems and the blood–brain barrier
por: Alyautdin, Renad, et al.
Publicado: (2014)

HAI Peptide and Backbone Analogs—Validation and Enhancement of Biostability and Bioactivity of BBB Shuttles
por: Arranz-Gibert, Pol, et al.
Publicado: (2018)

The blood–brain barrier: structure, regulation, and drug delivery
por: Wu, Di, et al.
Publicado: (2023)

Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
por: Pardridge, William M.
Publicado: (2020)

Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
por: Luo, Huilong, et al.
Publicado: (2020)

Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches
por: Velasco-Aguirre, Carolina, et al.
Publicado: (2015)

Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrier
por: Shin, Jung-Won, et al.
Publicado: (2022)

Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
por: Lee, David, et al.
Publicado: (2021)

Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
por: Upadhyay, Ravi Kant
Publicado: (2014)

In vitro characterization of odorranalectin for peptide-based drug delivery across the blood–brain barrier
por: Sajja, Ravi K., et al.
Publicado: (2019)

Plant Exosome-like Nanoparticles as Biological Shuttles for Transdermal Drug Delivery
por: Wang, Ye, et al.
Publicado: (2023)

Advanced Blood–Brain Barrier Drug Delivery
por: Pardridge, William M.
Publicado: (2022)

Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier
por: Teleanu, Raluca Ioana, et al.
Publicado: (2022)

Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
por: Silva, Gabriel A
Publicado: (2008)

Bypassing the Blood–Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies
por: Gernert, Manuela, et al.
Publicado: (2020)

THER-11. PEPTIDE-MEDIATED PERMEABILIZATION OF THE BLOOD-BRAIN BARRIER IMPROVES DRUG DELIVERY TO BRAIN METASTASIS
por: Aasen, Synnøve Nymark, et al.
Publicado: (2019)

Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood–Brain Tumour Barrier
por: Barzegar-Fallah, Anita, et al.
Publicado: (2022)

Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
por: Parodi, Alessandro, et al.
Publicado: (2019)

Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier
por: Georgieva, Julia V., et al.
Publicado: (2014)

Oligoarginine Peptide Conjugated to BSA Improves Cell Penetration of Gold Nanorods and Nanoprisms for Biomedical Applications
por: Bolaños, Karen, et al.
Publicado: (2021)

The Blood-Brain Barrier: Clinical Implications for Drug Delivery to the Brain
por: De Boer, A G, et al.
Publicado: (1994)

MiniAp‐4: A Venom‐Inspired Peptidomimetic for Brain Delivery
por: Oller‐Salvia, Benjamí, et al.
Publicado: (2015)

Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma
por: Zhang, Fang, et al.
Publicado: (2015)

Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting
por: Marianecci, Carlotta, et al.
Publicado: (2017)

Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier
por: Vieira, Débora B, et al.
Publicado: (2016)

On the shuttling across the blood-brain barrier via tubule formation: Mechanism and cargo avidity bias
por: Tian, Xiaohe, et al.
Publicado: (2020)

Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology
por: Hersh, Andrew M., et al.
Publicado: (2022)

Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective
por: Chaulagain, Bivek, et al.
Publicado: (2023)

The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier
por: Wei, Shuang-Shuang, et al.
Publicado: (2023)

Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
por: Niazi, Sarfaraz K.
Publicado: (2023)

Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies
por: Han, Liang, et al.
Publicado: (2021)

Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier
por: Khan, Mohammad Sameer, et al.
Publicado: (2023)

Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with Diclofenac
por: Mohammed, Yousuf, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hsh4emm6svu7i452mtc9tkafpt